SCLX Stock Analysis: Buy, Sell, or Hold?
SCLX - Scilex Holding Company Common Stock
$7.11
0.02 (0.28%)
▲
5d:
-4.82%
30d:
+4.41%
90d:
+8.05%
BUY
MODERATE Confidence
Analysis Updated: Jun 26, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When SCLX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SCLX shows positive signals but monitor for confirmation. Market pricing in 14.7% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: SCLX shows positive signals but monitor for confirmation. Market pricing in 14.7% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$6.65
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.13
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SCLX is currently trading at $7.11, which is considered fair relative to its 30-day fair value range of $6.38 to $8.05. From a valuation perspective, the stock is trading at a premium (Forward PE: 9.7) compared to its historical average (6.5). At these levels, the market is pricing in 14.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SCLX is in a downtrend. Immediate support is located at $6.11, while resistance sits at $9.74.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $490.00 (+6791.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SCLX is in a downtrend. Immediate support is located at $6.11, while resistance sits at $9.74.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $490.00 (+6791.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$6.38 -
$8.05
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 6791.7% below Wall St target ($490.00)
- NEUTRAL: Trading at premium valuation - market expects 14.7% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$6.38 -
$8.05
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$6.11
Resistance Level
$9.75
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.74
Wall Street Target
$490.00
(+6791.7%)
Revenue Growth (YoY)
72.1%
Valuation Premium vs History
+14.7% premium
PE vs Historical
9.7 vs 6.5
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+14.7%
(market-implied from PE analysis)
1-Year Target
$8.16
(+15%)
2-Year Target
$9.35
(+32%)
3-Year Target
$10.73
(+51%)
3-Yr Target (if PE normalizes)
(PE: 10→7)
PE COMPRESSION
$7.16
(+1%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: June 28, 2026 11:35 AM ET
Data refreshes hourly during market hours. Next update: 12:35 PM
Data refreshes hourly during market hours. Next update: 12:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SCLX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1223 | 56 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 64 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$220 | 69 BUY |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$254 | 64 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$353 | 61 BUY |
